1.
Racil Z, Razga F, Drapalova J, Buresova L, Zackova D, Palackova M, Semerad L, Malaskova L, Haluzik M, Mayer J. Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia. Haematologica [Internet]. 2013Oct.3 [cited 2026Nov.22];98(10):e124-e126. Available from: https://haematologica.org/article/view/6819